Psychotropic Medications Administered Without Signed Consent
Summary
Two residents with severe cognitive impairment and dementia were administered psychotropic medications without proper consent documentation. One resident, diagnosed with major depressive disorder and early-onset Alzheimer's disease, was prescribed Lorazepam for anxiety, and the family guardian was not informed of the new medication order. Although a request for consent was initiated, a signed consent was not obtained or available for review. Another resident with dementia received Zyprexa, an antipsychotic, without a signed consent present in the medical record at the time of survey exit. These findings reflect that psychotropic medications were administered to residents without the required signed consents, as confirmed by medical record review and family interview, and the necessary documentation was not available during the survey.
Plan Of Correction
Committee monthly for review. The QAPI Committee will be responsible for changes to the auditing process. The Administrator is responsible to attain and maintain compliance. Compliance Date: 6/20/2025
Penalty
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.
